Improved myocardial perfusion and cardiac function by controlled-release basic fibroblast growth factor using fibrin glue in a canine infarct model

Journal of Zhejiang University: Science B

Volumn 11, Issue 12, 2010, Pages 895-904

  Nie, Shao Ping ^a   Wang, Xiao ^a   Qiao, Shi Bin ^a   Zeng, Qiu Tang ^b   Jiang, Ju Quan ^b   Liu, Xiao Qing ^b   Zhu, Xiang Ming ^b   Cao, Guo Xiang ^b   Ma, Chang Sheng ^a  

^a CAPITAL MEDICAL UNIVERSITY   (China)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Angiogenesis; Basic fibroblast growth factor; Controlled release; Ischemic heart disease

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; BLOOD CLOTTING FACTOR 8; FIBRIN GLUE; FIBROBLAST GROWTH FACTOR 2;

ACUTE HEART INFARCTION; ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL DIAMETER; CONTROLLED DRUG RELEASE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFICACY; DRUG FATALITY; ECHOCARDIOGRAPHY; EXPERIMENTAL DOG; HEART FUNCTION; HEART MUSCLE PERFUSION; HEART PERFORMANCE; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SURGICAL MORTALITY; ANIMAL; DELAYED RELEASE FORMULATION; DISEASE MODEL; DOG; HEART; HEART INFARCTION; MYOCARDIAL PERFUSION IMAGING; PATHOPHYSIOLOGY; SCINTISCANNING;

ANIMALIA;

ANIMALS; DELAYED-ACTION PREPARATIONS; DISEASE MODELS, ANIMAL; DOGS; FACTOR VIII; FIBRIN TISSUE ADHESIVE; FIBROBLAST GROWTH FACTOR 2; HEART; MALE; MYOCARDIAL INFARCTION; MYOCARDIAL PERFUSION IMAGING; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79953016206     PISSN: 16731581     EISSN: 18621783     Source Type: Journal    
DOI: 10.1631/jzus.B1000302     Document Type: Article

References (36)

1. Beenken, A., Mohammadi, M., 2009. The FGF family: Biology, pathophysiology and therapy. Nat. Rev. Drug Discov., 8(3):235-253. [doi:10.1038/nrd2792]
2. Bourdillon, P.D., Broderick, T.M., Sawada, S.G., Armstrong, W.F., Ryan, T., Dillon, J.C., Fineberg, N.S., Feigenbaum, H., 1989. Regional wall motion index for infarct and noninfarct regions after reperfusion in acute myocardial infarction: Comparison with global wall motion index. J. Am. Soc. Echocardiogr., 2(6):398-407.
3. Brown, K.J., Maynes, S.F., Bezos, A., Maguire, D.J., Ford, M.D., Parish, C.R., 1996. A novel in vitro assay for human angiogenesis. Lab. Invest., 75(4):539-555. (Pubitemid 26346804)
4. Chawla, P.S., Keelan, M.H., Kipshidze, N., 1999. Angiogenesis for the treatment of vascular diseases. Int. Angiol., 18(3):185-192. (Pubitemid 30040639)
5. 165 in pigs. Ann. Thorac. Surg., 82(2):679-686. [doi:10.1016/j.athoracsur. 2006.03.028] (Pubitemid 44080035)
6. Currie, L.J., Sharpe, J.R., Martin, R., 2001. The use of fibrin glue in skin grafts and tissue-engineered skin replacements: A review. Plast. Reconstr. Surg., 108(6):1713-1726. [doi:10.1097/00006534-200111000-00045] (Pubitemid 33032643)
7. DeBlois, C., Cote, M.F., Doillon, C.J., 1994. Heparinfibroblast growth factor-fibrin complex: In vitro and in vivo applications to collagen-based materials. Biomaterials, 15(9):665-672. [doi:10.1016/0142-9612(94)90164-3]
8. Fasol, R., Schumacher, B., Schlaudraff, K., Hauenstein, K.H., Seitelberger, R., 1994. Experimental use of a modified fibrin glue to induce site-directed angiogenesis from the aorta to the heart. J. Thorac. Cardiovasc. Surg., 107(6): 1432-1439. (Pubitemid 24184982)
9. Germano, G., Kavanagh, P.B., Waechter, P., Areeda, J., van Kriekinge, S., Sharir, T., Lewin, H.C., Berman, D.S., 2000. A new algorithm for the quantitation of myocardial perfusion SPECT. I: Technical principles and reproducibility. J. Nucl. Med., 41(4):712-719. (Pubitemid 30207750)
10. Harada, K., Grossman, W., Friedman, M., Edelman, E.R., Prasad, P.V., Keighley, C.S., Manning, W.J., Sellke, F.W., Simons, M., 1994. Basic fibroblast growth factor improves myocardial function in chronically ischemic porcine hearts. J. Clin. Invest., 94(2):623-630. [doi:10. 1172/JCI117378] (Pubitemid 24250992)
11. 121) gene therapy for chronic myocardial ischemia-do the effects really add up? Eur. J. Cardiothorac. Surg., 23(1):74-80. [doi: 10.1016/S1010-7940(02)00718-2] (Pubitemid 35472101)
12. Henry, T.D., Annex, B.H., McKendall, G.R., Azrin, M.A., Lopez, J.J., Giordano, F.J., Shah, P.K., Willerson, J.T., Benza, R.L., Berman, D.S., et al., 2003. The VIVA trial: Vascular endothelial growth factor in ischemia for vascular angiogenesis. Circulation, 107(10):1359-1365. [doi: 10.1161/01.CIR.0000061911.47710.8A] (Pubitemid 36350732)
13. Henry, T.D., Grines, C.L., Watkins, M.W., Dib, N., Barbeau, G., Moreadith, R., Andrasfay, T., Engler, R.L., 2007. Effects of Ad5FGF-4 in patients with angina: An analysis of pooled data from the AGENT-3 and AGENT-4 trials. J. Am. Coll. Cardiol., 50(11):1038-1046. [doi:10.1016/j.jacc. 2007.06.010] (Pubitemid 47354223)
14. House, S.L., Bolte, C., Zhou, M., Doetschman, T., Klevitsky, R., Newman, G., Schultz Jel, J., 2003. Cardiac-specific overexpression of fibroblast growth factor-2 protects against myocardial dysfunction and infarction in a murine model of low-flow ischemia. Circulation, 108(25):3140-3148. [doi:10.1161/01.CIR. 0000105723.91637.1C] (Pubitemid 38031805)
15. Hughes, G.C., Kypson, A.P., St. Louis, J.D., Annex, B.H., Coleman, R.E., DeGrado, T.R., Donovan, C.L., Lowe, J.E., Landolfo, K.P., 1999. Improved perfusion and contractile reserve after transmyocardial laser revascularization in a model of hibernating myocardium. Ann. Thorac. Surg., 67(6):1714-1720. [doi:10.1016/S0003-4975(99)00 317-3] (Pubitemid 29301316)
16. Iwakura, A., Fujita, M., Kataoka, K., Tambara, K., Sakakibara, Y., Komeda, M., Tabata, Y., 2003. Intramyocardial sustained delivery of basic fibroblast growth factor improves angiogenesis and ventricular function in a rat infarct model. Heart Vessels, 18(2):93-99. [doi:10.1007/s10380- 002-0686-5] (Pubitemid 36701553)
17. Jeon, O., Ryu, S.H., Chung, J.H., Kim, B.S., 2005. Control of basic fibroblast growth factor release from fibrin gel with heparin and concentrations of fibrinogen and thrombin. J. Control Release, 105(3):249-259. [doi:10.1016/j.jconrel. 2005.03.023] (Pubitemid 40941990)
18. Jiang, Z.S., Srisakuldee, W., Soulet, F., Bouche, G., Kardami, E., 2004. Non-angiogenic FGF-2 protects the ischemic heart from injury, in the presence or absence of reperfusion. Cardiovasc. Res., 62(1):154-166. [doi:10.1016/j. cardiores.2004.01.009] (Pubitemid 38326821)
19. Kang, S.S., Gosselin, C., Ren, D., Greisler, H.P., 1995. Selective stimulation of endothelial cell proliferation with inhibition of smooth muscle cell proliferation by fibroblast growth factor-1 plus heparin delivered from fibrin glue suspensions. Surgery, 118(2):280-287. [doi:10.1016/S00 39-6060(05)80335-6]
20. Karacal, N., Cobanoglu, U., Ambarcioglu, O., Kutlu, N., 2007. The effect of fibrin glue on fat graft survival. J. Plast. Reconstr. Aesthet. Surg., 60(3):300-303. [doi:10.1016/ j.bjps.2006.03.051] (Pubitemid 46206861)
21. Kastrup, J., Jorgensen, E., Ruck, A., Tagil, K., Glogar, D., Ruzyllo, W., Botker, H.E., Dudek, D., Drvota, V., Hesse, B., et al., 2005. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized doubleblind placebo-controlled study: The Euroinject One trial. J. Am. Coll. Cardiol., 45(7):982-988. [doi:10.1016/j.jacc. 2004.12.068] (Pubitemid 40432426)
22. Kawasuji, M., Nagamine, H., Ikeda, M., Sakakibara, N., Takemura, H., Fujii, S., Watanabe, Y., 2000. Therapeutic angiogenesis with intramyocardial administration of basic fibroblast growth factor. Ann. Thorac. Surg., 69(4): 1155-1161. [doi:10.1016/S0003-4975(99)01557-X] (Pubitemid 30259378)
23. Kornowski, R., Fuchs, S., Leon, M.B., Epstein, S.E., 2000a. Delivery strategies to achieve therapeutic myocardial angiogenesis. Circulation, 101(4):454-458. (Pubitemid 30067404)
24. Kornowski, R., Baim, D.S., Moses, J.W., Hong, M.K., Laham, R.J., Fuchs, S., Hendel, R.C., Wallace, D., Cohen, D.J., Bonow, R.O., et al., 2000b. Short- and intermediate-term clinical outcomes from direct myocardial laser revascularization guided by Biosense left ventricular electromechanical mapping. Circulation, 102(10):1120-1125.
25. Laham, R.J., Garcia, L., Baim, D.S., Post, M., Simons, M., 1999. Therapeutic angiogenesis using basic fibroblast growth factor and vascular endothelial growth factor using various delivery strategies. Curr. Interv. Cardiol. Rep., 1(3):228-233.
26. Laham, R.J., Chronos, N.A., Pike, M., Leimbach, M.E., Udelson, J.E., Pearlman, J.D., Pettigrew, R.I., Whitehouse, M.J., Yoshizawa, C., Simons, M., 2000. Intracoronary basic fibroblast growth factor (FGF-2) in patients with severe ischemic heart disease: Results of a phase I open-label dose escalation study. J. Am. Coll. Cardiol., 36(7):2132-2139. [doi:10.1016/S0735-1097(00) 00988-8]
27. Lopez, J.J., Edelman, E.R., Stamler, A., Hibberd, M.G., Prasad, P., Caputo, R.P., Carrozza, J.P., Douglas, P.S., Sellke, F.W., Simons, M., 1997. Basic fibroblast growth factor in a porcine model of chronic myocardial ischemia: A comparison of angiographic, echocardiographic and coronary flow parameters. J. Pharmacol. Exp. Ther., 282(1):385-390. (Pubitemid 27425565)
28. Phelps, E.A., Garcia, A.J., 2009. Update on therapeutic vascularization strategies. Regen. Med., 4(1):65-80. [doi: 10.2217/17460751.4.1.65]
29. Post, M.J., Laham, R., Sellke, F.W., Simons, M., 2001. Therapeutic angiogenesis in cardiology using protein formulations. Cardiovasc. Res., 49(3):522-531. [doi:10. 1016/S0008-6363(00)00216-9] (Pubitemid 32146415)
30. Sahni, A., Odrljin, T., Francis, C.W., 1998. Binding of basic fibroblast growth factor to fibrinogen and fibrin. J. Biol. Chem., 273(13):7554-7559. [doi:10.1074/jbc.273.13.7554] (Pubitemid 28152781)
31. Sahni, A., Khorana, A.A., Baggs, R.B., Peng, H., Francis, C.W., 2006. FGF-2 binding to fibrin(ogen) is required for augmented angiogenesis. Blood, 107(1):126-131. [doi: 10.1182/blood-2005-06-2460] (Pubitemid 43053533)
32. Shao, Z.Q., Takaji, K., Katayama, Y., Kunitomo, R., Sakaguchi, H., Lai, Z.F., Kawasuji, M., 2006. Effects of intramyocardial administration of slow-release basic fibroblast growth factor on angiogenesis and ventricular remodeling in a rat infarct model. Circ. J., 70(4):471-477. [doi:10.1253/circj. 70.471]
33. Simons, M., Annex, B.H., Laham, R.J., Kleiman, N., Henry, T., Dauerman, H., Udelson, J.E., Gervino, E.V., Pike, M., Whitehouse, M.J., et al., 2002. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: Double-blind, randomized, controlled clinical trial. Circulation, 105(7):788-793. [doi: 10.1161/hc0802.104407] (Pubitemid 34174916)
34. Stewart, D.J., Kutryk, M.J., Fitchett, D., Freeman, M., Camack, N., Su, Y., Della Siega, A., Bilodeau, L., Burton, J.R., Proulx, G., et al., 2009. VEGF gene therapy fails to improve perfusion of ischemic myocardium in patients with advanced coronary disease: Results of the NORTHERN trial. Mol. Ther., 17(6):1109-1115. [doi:10.1038/mt.20 09.70]
35. Sutton, M.G., Sharpe, N., 2000. Left ventricular remodeling after myocardial infarction: Pathophysiology and therapy. Circulation, 101(25):2981-2988. (Pubitemid 30415891)
36. Yamamoto, N., Kohmoto, T., Roethy, W., Gu, A., DeRosa, C., Rabbani, L.E., Smith, C.R., Burkhoff, D., 2000. Histologic evidence that basic fibroblast growth factor enhances the angiogenic effects of transmyocardial laser revascularization. Basic Res. Cardiol., 95(1):55-63. [doi: 10.1007/ s003950050008] (Pubitemid 30150728)